XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Debt securities, available for sale:      
Amortized Cost $ 72.9   $ 210.7
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   (0.1)
Estimated Market Value 72.9 $ 210.6 210.6
Total marketable securities      
Cost or Amortized Cost     212.7
Gross Unrealized Gains     36.0
Gross Unrealized Losses     (0.1)
Estimated Market Value 72.9   248.6
Equity Securities Net Gain      
Net gains recognized during the period on equity securities (4.2) 7.4  
U.S. government agencies      
Debt securities, available for sale:      
Amortized Cost 54.8   173.2
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   (0.1)
Estimated Market Value 54.8 173.1 173.1
Commercial paper      
Debt securities, available for sale:      
Amortized Cost 3.0   36.2
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   0.0
Estimated Market Value 3.0 36.2 36.2
Corporate debt      
Debt securities, available for sale:      
Amortized Cost 15.1   1.3
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   0.0
Estimated Market Value $ 15.1 $ 1.3 1.3
Equity investment in Tandem Diabetes Care, Inc      
Equity investment in Tandem Diabetes Care, Inc.      
Cost or Amortized Cost     2.0
Gross Unrealized Gains     36.0
Gross Unrealized Losses     0.0
Estimated Market Value     $ 38.0